Hamilton and Biosero Announce Co-Marketing Agreement to Optimize Automated Liquid Handling Workflows
Hamilton and Biosero, Inc., developer of laboratory automation solutions to orchestrate scientific discoveries, today announced a strategic co-marketing agreement aimed at streamlining automated ...
The system is especially useful for high-throughput target enrichment of cell free DNA (cfDNA) fragments and other NGS library constructs via gel-based size selection prior to sequencing. The ...
SAN DIEGO, Sept. 27, 2022 /PRNewswire/ -- Biofluidica, Inc., and Hamilton Company, today announced a co-marketing agreement to bring advanced Liquid Biopsy capabilities to laboratories worldwide.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback